FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085662337> ?p ?o ?g. }

• W2085662337 endingPage "704" @default.
• W2085662337 startingPage "695" @default.
• W2085662337 abstract "PurposeTo investigate the potential effect of using 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) in the initial assessment of patients with clinical Stage II or III breast cancer.Methods and MaterialsDuring 14 consecutive months, 39 patients (40 tumors) who presented with Stage II or III breast cancer on the basis of a routine extension assessment were prospectively included in this study. PET/CT was performed in addition to the initial assessment.ResultsIn 3 cases, PET/CT showed extra-axillary lymph node involvement that had not been demonstrated with conventional techniques. Two of these patients had hypermetabolic lymph nodes in the subpectoral and infraclavicular regions, and the third had a hypermetabolic internal mammary node. PET/CT showed distant uptake in 4 women. Of these 4 women, 1 had pleural involvement and 3 had bone metastasis. Overall, of the 39 women, the PET/CT results modified the initial stage in 7 (18%). The modified staging altered the treatment plan for 5 patients (13%). It led to radiotherapy in 4 patients (bone metastasis, pleural lesion, subpectoral lymph nodes, and internal mammary nodes) and excision of, and radiotherapy to, the infraclavicular lymph nodes in 1 patient.ConclusionsPET/CT can provide information on extra-axillary lymph node involvement and can uncover occult distant metastases in a significant percentage of patients. Therefore, initial PET/CT could enable better treatment planning for patients with Stage II and III breast cancer. To investigate the potential effect of using 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) in the initial assessment of patients with clinical Stage II or III breast cancer. During 14 consecutive months, 39 patients (40 tumors) who presented with Stage II or III breast cancer on the basis of a routine extension assessment were prospectively included in this study. PET/CT was performed in addition to the initial assessment. In 3 cases, PET/CT showed extra-axillary lymph node involvement that had not been demonstrated with conventional techniques. Two of these patients had hypermetabolic lymph nodes in the subpectoral and infraclavicular regions, and the third had a hypermetabolic internal mammary node. PET/CT showed distant uptake in 4 women. Of these 4 women, 1 had pleural involvement and 3 had bone metastasis. Overall, of the 39 women, the PET/CT results modified the initial stage in 7 (18%). The modified staging altered the treatment plan for 5 patients (13%). It led to radiotherapy in 4 patients (bone metastasis, pleural lesion, subpectoral lymph nodes, and internal mammary nodes) and excision of, and radiotherapy to, the infraclavicular lymph nodes in 1 patient. PET/CT can provide information on extra-axillary lymph node involvement and can uncover occult distant metastases in a significant percentage of patients. Therefore, initial PET/CT could enable better treatment planning for patients with Stage II and III breast cancer." @default.
• W2085662337 created "2016-06-24" @default.
• W2085662337 creator A5014023740 @default.
• W2085662337 creator A5014743590 @default.
• W2085662337 creator A5018124634 @default.
• W2085662337 creator A5026852302 @default.
• W2085662337 creator A5028353199 @default.
• W2085662337 creator A5033300153 @default.
• W2085662337 creator A5034569354 @default.
• W2085662337 creator A5038243932 @default.
• W2085662337 creator A5057420179 @default.
• W2085662337 creator A5081308456 @default.
• W2085662337 creator A5085761835 @default.
• W2085662337 creator A5088538374 @default.
• W2085662337 creator A5091451151 @default.
• W2085662337 date "2008-07-01" @default.
• W2085662337 modified "2023-10-11" @default.
• W2085662337 title "Effect of 18F-FDG PET/CT Imaging in Patients With Clinical Stage II and III Breast Cancer" @default.
• W2085662337 cites W1542390137 @default.
• W2085662337 cites W1762109430 @default.
• W2085662337 cites W1852741248 @default.
• W2085662337 cites W1939379735 @default.
• W2085662337 cites W1967756881 @default.
• W2085662337 cites W1972112174 @default.
• W2085662337 cites W1975816551 @default.
• W2085662337 cites W1978203964 @default.
• W2085662337 cites W1997387815 @default.
• W2085662337 cites W2002145756 @default.
• W2085662337 cites W2006139754 @default.
• W2085662337 cites W2008283057 @default.
• W2085662337 cites W2011240752 @default.
• W2085662337 cites W2012925863 @default.
• W2085662337 cites W2028085888 @default.
• W2085662337 cites W2030022804 @default.
• W2085662337 cites W2031950319 @default.
• W2085662337 cites W2035655339 @default.
• W2085662337 cites W2057764822 @default.
• W2085662337 cites W2073663008 @default.
• W2085662337 cites W2081073831 @default.
• W2085662337 cites W2109020284 @default.
• W2085662337 cites W2110094406 @default.
• W2085662337 cites W2114172341 @default.
• W2085662337 cites W2132434084 @default.
• W2085662337 cites W2148781450 @default.
• W2085662337 cites W2153369531 @default.
• W2085662337 cites W2158356070 @default.
• W2085662337 cites W2162268087 @default.
• W2085662337 cites W2177221443 @default.
• W2085662337 cites W2317678348 @default.
• W2085662337 cites W2319001023 @default.
• W2085662337 doi "https://doi.org/10.1016/j.ijrobp.2008.02.056" @default.
• W2085662337 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18436392" @default.
• W2085662337 hasPublicationYear "2008" @default.
• W2085662337 type Work @default.
• W2085662337 sameAs 2085662337 @default.
• W2085662337 citedByCount "104" @default.
• W2085662337 countsByYear W20856623372012 @default.
• W2085662337 countsByYear W20856623372013 @default.
• W2085662337 countsByYear W20856623372014 @default.
• W2085662337 countsByYear W20856623372015 @default.
• W2085662337 countsByYear W20856623372016 @default.
• W2085662337 countsByYear W20856623372017 @default.
• W2085662337 countsByYear W20856623372018 @default.
• W2085662337 countsByYear W20856623372019 @default.
• W2085662337 countsByYear W20856623372020 @default.
• W2085662337 countsByYear W20856623372021 @default.
• W2085662337 countsByYear W20856623372022 @default.
• W2085662337 countsByYear W20856623372023 @default.
• W2085662337 crossrefType "journal-article" @default.
• W2085662337 hasAuthorship W2085662337A5014023740 @default.
• W2085662337 hasAuthorship W2085662337A5014743590 @default.
• W2085662337 hasAuthorship W2085662337A5018124634 @default.
• W2085662337 hasAuthorship W2085662337A5026852302 @default.
• W2085662337 hasAuthorship W2085662337A5028353199 @default.
• W2085662337 hasAuthorship W2085662337A5033300153 @default.
• W2085662337 hasAuthorship W2085662337A5034569354 @default.
• W2085662337 hasAuthorship W2085662337A5038243932 @default.
• W2085662337 hasAuthorship W2085662337A5057420179 @default.
• W2085662337 hasAuthorship W2085662337A5081308456 @default.
• W2085662337 hasAuthorship W2085662337A5085761835 @default.
• W2085662337 hasAuthorship W2085662337A5088538374 @default.
• W2085662337 hasAuthorship W2085662337A5091451151 @default.
• W2085662337 hasBestOaLocation W20856623371 @default.
• W2085662337 hasConcept C121608353 @default.
• W2085662337 hasConcept C126322002 @default.
• W2085662337 hasConcept C126838900 @default.
• W2085662337 hasConcept C142724271 @default.
• W2085662337 hasConcept C146357865 @default.
• W2085662337 hasConcept C151730666 @default.
• W2085662337 hasConcept C204787440 @default.
• W2085662337 hasConcept C2775842073 @default.
• W2085662337 hasConcept C2777415128 @default.
• W2085662337 hasConcept C2777649267 @default.
• W2085662337 hasConcept C2779013556 @default.
• W2085662337 hasConcept C2779720271 @default.
• W2085662337 hasConcept C2780849966 @default.
• W2085662337 hasConcept C2989005 @default.
• W2085662337 hasConcept C509974204 @default.

• next